Category: Life Sciences
WEBCAST: Liability in Times of Change for the Life Sciences Industry
The growth of digital health technologies and artificial intelligence raises novel risks, including data protection and cybersecurity risks, and key questions about the liability of services and software as a product remain unanswered. Wearables are blurring the line between consumer technology and medical devices, and consumer health data has the […]
UK’s medicines and medical devices regulator to tackle Brexit, technological advancements and regulatory challenges (including from COVID-19) in 2020 and 2021
Sarah-Jane Dobson and Amal Ali
The MHRA has established five strategic goals for 2020-21 that will impact all those operating in the UK medicines and medical devices industries
The Science of Regulation and the Regulation of Science
Sarah-Jane Dobson and Sumiyya Abdur-Rahman
The EU’s Five-Year Strategy for Modern Human Medicines
COVID-19: Weekly Life Sciences Digest – International Collaboration and Adjusted Exports/Import Rules
Sarah-Jane Dobson, Edward Turtle and Alicia Johnson-Cole
With COVID-19 heralding unprecedented changes in the sector, our life sciences products experts provide a weekly summary of key international developments to keep you up to date.
Flexibility for our furry friends
Sarah-Jane Dobson and Olivia Flasch
EU regulators have taken steps to address supply chain disruption and increased demand in veterinary medicines caused by the COVID-19 pandemic.
COVID-19: Weekly Life Sciences Digest – Testing Kits for COVID-19
Natasha Leskovsek, Andrew Barr, Sarah-Jane Dobson, Edward Turtle, Harriet Jones and Julia Maskell
With COVID-19 heralding unprecedented changes in the sector, our life sciences products experts provide a weekly summary of key international developments to keep you up to date.
UK-specific guidance for the application and management of clinical trials in the context of COVID-19
Sarah-Jane Dobson and Amal Ali
The UK’s MHRA has stated it will be particularly flexible and pragmatic in authorising clinical trials connected to COVID-19, referring to its previous track record of having acted swiftly in past public health crises
COVID-19: Weekly Life Sciences Digest – PPE in EU and UK
Sarah-Jane Dobson, Edward Turtle, Harriet Jones and Julia Maskell
With COVID-19 heralding unprecedented changes in the sector, our life sciences products experts provide a weekly summary of key international developments to keep you up to date.
COVID-19: Weekly Life Sciences Digest – Initiatives for Fast Tracking Treatments and New FDA Guidance
Phil Mitchell, Edward Turtle, Sana Shakir, Julia Maskell and Alicia Johnson-Cole
With COVID-19 heralding unprecedented changes in the sector, our life sciences products experts provide a weekly summary of key international developments to keep you up to date.
COVID-19: Weekly Life Sciences Digest – International Collaboration and New Guidance in the EU and UK
Sarah-Jane Dobson, Edward Turtle and Julia Maskell
With COVID-19 heralding unprecedented changes in the sector, our life sciences products experts provide a weekly summary of key international developments to keep you up to date.